ReviewJournal of diabetes and metabolic disorders2025

Cardiovascular outcomes of SGLT-2 inhibitors' subtypes in type 2 diabetes; an updated systematic review and meta-analysis of randomized controlled trials.

Pouya Ebrahimi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.